The 1,1-bis(3'-indolyl)-1-(p-substituted phenyl)methanes containing p-trifluoromethyl, p-tbutyl, or p-phenyl (CDIM9) substituents were initially identified as a novel class of PPAR-γ agonists in breast cancer cells [25]. Here, PPARG is linked to breast cancer.